Clinical Pathways

Latest Content


Latest Videos


More News

The FDA has expanded its approval of ribociclib (Kisqali) to treat hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer under 2 new pilot programs to make the development and review of cancer drugs more efficient.

Using a series of small public data sets, researchers found a positive association of prenatal exposure to folic acid fortification with subsequent cortical development in the brain—considered key for cognitive and mental health—through adolescence. The finding suggests that increased prenatal exposure to folic acid through food fortification may protect against psychosis through altered postnatal cortical development.